

Patient-Reported Experience Measures for People Living with Rare Diseases (RD-PREM)
On This Page

Introduction
The RD-PREM Project is a collaborative initiative led by three core research partners:
- University College Dublin (UCD), School of Nursing, Midwifery and Health Systems, Dublin
- EURORDIS – Rare Diseases Europe
- Rare Diseases Ireland (RDI)
Funded by the Health Research Board (HRB) under the Rare Disease Catalyst Award (Grant No. R26672), this project aims to design, develop, and validate patient-reported experience measures (PREMs) that are specifically tailored to the needs of individuals living with rare diseases.
These tools will capture real, meaningful insights into patient experiences with healthcare, supporting more person-centred services, better care delivery, and more informed policy in the rare disease space.
Why the RD-PREM Project Matters
Rare diseases pose unique challenges:
- Low prevalence and fragmented expertise across healthcare systems
- Limited access to coordinated care
- Barriers to consistent patient feedback collection
Despite progress through the European Reference Networks (ERNs)—collaborative hubs for rare disease care involving over 300 hospitals—there remains no validated PREM framework that can be used across all rare diseases.
RD-PREM fills this gap, enabling healthcare systems to:
- Systematically measure patient experience
- Compare care across regions and conditions
- Improve healthcare quality, governance, and accountability
Project Goals
We aim to develop validated, accessible RD-PREM questionnaires that:
- Enable adult rare disease patients to self-report their healthcare experiences
- Allow family members/carers to report experiences on behalf of patients unable to self-report
- Develop child-friendly versions for patients under 18
Project Methodology
The project employs a participatory, multiple-method, and multi-phase approach. This ensures diverse and continuous involvement from:
- People living with rare diseases
- Family carers and advocates
- Clinicians and hospital administrators
- Researchers and policymakers
To maximise reach and inclusion, we use both in-person and online engagement, leveraging EURORDIS’ established platforms for survey distribution and expert recruitment.
Acknowledgments
The RD-PREM Project is made possible by the Health Research Board and the passionate efforts of our research partners, clinical collaborators, patient advocates, and—most importantly—individuals living with rare diseases who share their stories and insights to shape a better future for all.
Project Timeline
-
Step 1 (EURORDIS)
Pilot H-CARE Survey confirms lack of PREMs for rare diseases (2019–2020)
-
Step 2 (EURORDIS)
Expert consultations and focus groups to design the first RD-PREM draft (2025)
-
Step 4 (HRB-RDCat, Ireland)
Testing & validation across five Irish hospital sites (2026)
-
Steps 5 & 6 (HRB-RDCat, Ireland)
Finalise, publish and disseminate validated RD-PREM tools (2027)
About RDCat
The Rare Disease Research Catalyst Consortium (RDCat) brings together healthcare professionals, researchers, and patient advocates across Ireland. Hosted by UCD and supported by institutions including:
- Royal College of Surgeons in Ireland (RCSI)
- Trinity College Dublin (TCD)
- Children’s Health Ireland
- Beaumont, Mater, St. Vincent’s, and Tallaght University Hospitals
Key partners include Rare Diseases Ireland and EURORDIS – Rare Diseases Europe. The Consortium is dedicated to advancing rare disease research and driving policy change through coordinated and collaborative action.
Project Team


Dr Stephanie Sangalang
Postdoctoral Researcher
University College Dublin

Vicky McGrath
Chief Executive
Rare Diseases Ireland
Dr Lucy Collins Stack
Research Project Manager
Rare Diseases Ireland
D. Jessie Dubief
Lead Researcher
EURORDIS